Sector Pulse — September 1, 2026

Technology

Theme

AI infrastructure remains the market’s dominant technology narrative, but leadership is broadening from GPUs into networking, optical connectivity, storage, power management, cybersecurity, and enterprise software. Rising Treasury yields continue to punish expensive, long-duration names even when operating results remain strong.

Movers

NVDA(NVIDIA) continues to expand from GPU supplier into an ecosystem platform, with its Nemotron models embedded in enterprise cybersecurity and its investments in optical and custom-silicon partners reinforcing control over the AI stack.
DELL(Dell Technologies) delivered a major AI infrastructure validation: $16.4 billion in AI-optimized server revenue, a $95 billion backlog, and $60.9 billion in AI orders. The stock’s sharp rally raises the bar for future execution.
AMD(Advanced Micro Devices) moved from promise to deployment with MI355X GPUs operating in Saudi Arabia through HUMAIN and Cisco. The planned 250 MW expansion and 1 GW target strengthen AMD’s sovereign-AI credentials, although U.S. export approvals remain a gating risk.
AVGO(Broadcom), MRVL(Marvell Technology), ANET(Arista Networks), CSCO(Cisco Systems), HPE(Hewlett Packard Enterprise), APH(Amphenol), CRDO(Credo Technology), COHR(Coherent), and LITE(Lumentum) all benefited from the same structural shift: data movement, optical links, switching, and custom silicon are becoming as critical as compute.
STX(Seagate Technology) is emerging as the storage leader, with HAMR and Mozaic supporting strong pricing, margin expansion, and AI-driven demand. WDC(Western Digital) remains a beneficiary but is losing relative momentum.
OKTA(Okta), CRWD(CrowdStrike), PANW(Palo Alto Networks), FTNT(Fortinet), ZS(Zscaler), NET(Cloudflare), and TENB(Tenable) are repositioning cybersecurity around AI-agent governance, autonomous response, and protection of non-human identities.
CRM(Salesforce), VEEV(Veeva Systems), TEAM(Atlassian), PAYC(Paycom), DDOG(Datadog), SNOW(Snowflake), and NTAP(NetApp) show that investors still reward enterprise software when AI adoption is tied to measurable workflows, retention, or backlog.
ORCL(Oracle), GOOG(Alphabet), GOOGL(Alphabet), and META(Meta Platforms) face the opposite test: massive AI capex must translate into durable monetization before depreciation and financing costs compress returns.
AMAT(Applied Materials), KLAC(KLA), LRCX(Lam Research), MCHP(Microchip Technology), MPWR(Monolithic Power Systems), ADI(Analog Devices), KEYS(Keysight Technologies), TXN(Texas Instruments), MU(Micron Technology), SNDK(Sandisk), and TSM(Taiwan Semiconductor Manufacturing) remain central to the semiconductor cycle. Strong results were repeatedly met with post-earnings selling, showing that expectations—not fundamentals alone—are setting price action.
INTC(Intel) delivered a meaningful recovery signal, but its 72.5x forward P/E and reliance on 18A execution leave little room for manufacturing delays.
IBM(IBM), SAP(SAP), WDAY(Workday), and NOW(ServiceNow) face an architectural challenge from AI-native, real-time ERP and workflow platforms such as Rillet. Incumbent switching costs remain high, but the threat is moving from feature competition to platform redesign.
SHOP(Shopify), PLTR(Palantir), APP(AppLovin), RBLX(Roblox), GDDY(GoDaddy), and PINS(Pinterest) illustrate the market’s sharper valuation discipline. Strong user or revenue growth is no longer sufficient when cash conversion, disclosure quality, or monetization remain uncertain.
IONQ(IonQ) produced one of the clearest commercial quantum milestones, demonstrating chemically accurate simulation for drug discovery. QBTS(D-Wave Quantum) also improved its revenue mix, but remains constrained by flat total revenue and limited hardware breakthroughs.
ARM(Arm Holdings) remains strategically important in AI and edge computing, but its proposed $800 million executive compensation package and 239x earnings multiple create a significant governance and valuation overhang.
ADBE(Adobe) is making a long-term ecosystem bet in Saudi Arabia by distributing Firefly and Express at scale. The opportunity is substantial, but the economics depend on converting a large free user base into paying customers.
GFS(Edgewater Wireless), U(Unity Software), GRMN(Garmin), and QCOM(Qualcomm) are targeting specialized growth in Wi-Fi silicon, immersive content, marine ecosystems, and on-device AI.

Actionable Ideas (Positive)

Buy weakness in semiconductor infrastructure rather than chase the highest-multiple AI platforms. AMAT(Applied Materials), KLAC(KLA), KEYS(Keysight Technologies), MPWR(Monolithic Power Systems), STX(Seagate Technology), and NTAP(NetApp) combine real cash generation with structural AI demand.
Overweight optical and networking enablers. COHR(Coherent), LITE(Lumentum), CRDO(Credo Technology), and ANET(Arista Networks) have direct exposure to the bandwidth bottleneck. NVIDIA’s strategic investment in optical suppliers materially strengthens the thesis.
Favor profitable or cash-generative cybersecurity platforms. CRWD(CrowdStrike), PANW(Palo Alto Networks), and OKTA(Okta) are converting AI-related risk into product demand, with agent security becoming a new spending category.
Use the pullback in KEYS(Keysight Technologies) as a tactical entry point. The 36.5% revenue increase and strongest guidance raise in its peer group support a bullish setup despite the negative post-earnings reaction.

Actionable Ideas (Negative)

Avoid or hedge overcapitalized AI infrastructure names with extreme financing risk. NBIS(Nebius Group), APLD(Applied Digital), CRWV(CoreWeave), and IREN(IREN) have large backlogs but also heavy capex, debt, lease commitments, or customer concentration. Their equity values require flawless execution.
Maintain a bearish bias on ORCL(Oracle) and META(Meta Platforms) if capex continues to outrun cash generation. Oracle’s negative free cash flow and Meta’s 91% cash-flow decline show that AI investment can create a valuation problem even when revenue growth is strong.
Treat PLTR(Palantir), CRWD(CrowdStrike), PANW(Palo Alto Networks), and FTNT(Fortinet) as vulnerable to multiple compression. Their operating momentum is strong, but valuations require sustained upside surprises in a rising-rate regime.
Stay cautious on MU(Micron Technology). Taiwan labor disruption, Chinese HBM competition, and the fungible nature of memory chips threaten the durability of the current supercycle.

Financials

Theme

Financials are benefiting from a steepening yield curve and elevated rates, which support net interest income and trading activity but raise funding, credit, and regulatory risks. The strongest stories combine fee diversification and capital discipline; the weakest rely on expensive leverage, aggressive M&A, or uncertain turnaround narratives.

Movers

JPM(JPMorgan Chase), GS(Goldman Sachs), SCHW(Charles Schwab), IBKR(Interactive Brokers), RJF(Raymond James), and SNEX(StoneX) are capturing the benefits of higher rates, market volatility, and resilient capital-markets activity.
BAC(Bank of America), PNC(PNC Financial Services), USB(U.S. Bancorp), BNS(Bank of Nova Scotia), TD(TD Bank), and RY(Royal Bank of Canada) are expanding commercial and U.S. footprints, but credit costs and execution are rising with ambition.
AXP(American Express), PYPL(PayPal), XYZ(Block), AFRM(Affirm), HOOD(Robinhood), and SOFI(SoFi Technologies) are pushing beyond payments into embedded lending, prediction markets, stablecoins, and data-driven underwriting.
AON(Aon) suffered a sharp selloff after its $17 billion debt-funded USI acquisition. The market is demanding leverage reduction and synergy delivery rather than rewarding scale for its own sake.
KKR(KKR) validated its strategic-holdings model through the USI exit, but the record HSR penalty highlights the increasing regulatory burden on private equity.
BLK(BlackRock), IVZ(Invesco), TROW(T. Rowe Price), and STT(State Street) are positioning around ETFs, personalized portfolios, and India’s asset-management growth.
V(Visa) continues to improve fraud controls while facing a potentially material DOJ challenge to debit-card economics.
HLI(Houlihan Lokey) and EG(Everest Group) delivered clear signs of pressure in advisory and reinsurance, while RNR(RenaissanceRe), KNSL(Kinsale Capital), and WRB(W.R. Berkley) are benefiting from disciplined underwriting.
LPLA(LPL Financial) lost a $2.1 billion advisor group, exposing retention risk just as it invests heavily in technology.

Actionable Ideas (Positive)

Prefer SCHW(Charles Schwab), IBKR(Interactive Brokers), and SNEX(StoneX) for operating momentum. Record trading activity, advisory flows, and volatility-linked revenue support earnings without requiring large balance-sheet leverage.
Favor RJF(Raymond James), BNS(Bank of Nova Scotia), and RY(Royal Bank of Canada) as diversified financials. Their earnings growth spans wealth management, capital markets, and commercial banking rather than relying solely on net interest margins.
Buy KKR(KKR) on regulatory-driven weakness. The USI realization demonstrates strong value creation and provides capital to redeploy, while the penalty is financially manageable even though compliance costs will rise.
Use KNSL(Kinsale Capital) and WRB(W.R. Berkley) as underwriting-quality exposures. Their willingness to reject underpriced risk should preserve margins as E&S pricing softens.

Actionable Ideas (Negative)

Avoid AON(Aon) until leverage reduction is visible. The debt-funded USI acquisition suspended buybacks and shifts the investment case from steady compounding to integration and balance-sheet execution.
Stay negative on V(Visa) if regulatory risk escalates. Changes to debit economics could permanently reduce pricing power despite strong network growth.
Avoid BEN(Franklin Resources) and remain cautious on EQH(Equitable Holdings). Stagnant earnings, weak returns, and institutional exits indicate that low valuation alone is not creating a catalyst.
Treat HOOD(Robinhood) and AFRM(Affirm) as high-beta positions. Their growth is real, but prediction-market regulation, underwriting risk, and premium valuations create asymmetric downside if the cycle turns.

Healthcare

Theme

Healthcare leadership is concentrating in precision diagnostics, GLP-1s, rare disease, and high-growth medical devices, while insurers focus on cost discipline. The strongest catalysts are regulatory approvals and payer coverage; the major risks are drug pricing intervention, clinical setbacks, and margin pressure from utilization.

Movers

MRNA(Moderna) delivered the sector’s clearest upside shock after Phase 3 success for its personalized melanoma vaccine with Merck. The result materially validates mRNA oncology beyond COVID.
LLY(Eli Lilly) continues to dominate the GLP-1 cycle with strong Mounjaro and Zepbound growth, but government pricing initiatives could pressure margins.
NVO(Novo Nordisk) gained a strategic foothold with the German oral Wegovy launch, although competition from Lilly and pricing pressure have weighed on sentiment.
GILD(Gilead Sciences), MRK(Merck), and GSK(GSK) are competing aggressively in next-generation HIV therapies. Gilead’s Bixlenvo approval and Merck’s weekly oral regimen raise the stakes for treatment convenience and market share.
ALNY(Alnylam Pharmaceuticals), BMRN(BioMarin), BBIO(BridgeBio Pharma), and VRTX(Vertex Pharmaceuticals) are expanding rare-disease franchises through strong products and acquisitions. Their valuations now depend heavily on regulatory execution.
GH(Guardant Health), NTRA(Natera), TEM(Tempus AI), VCYT(Veracyte), and ILMN(Illumina) are advancing liquid biopsy and genomic diagnostics from research tools into reimbursed clinical workflows.
MDT(Medtronic), SYK(Stryker), ISRG(Intuitive Surgical), EW(Edwards Lifesciences), and GMED(Globus Medical) are increasing exposure to robotics, structural heart, and digital surgery.
CNC(Centene), ELV(Elevance Health), and UNH(UnitedHealth) are prioritizing underwriting profitability over enrollment growth. Centene’s sharp medical-cost improvement is the clearest turnaround signal.
BAX(Baxter), HCA(HCA Healthcare), and ZTS(Zoetis) showed the other side of the sector: weak earnings momentum, guidance pressure, or stagnant demand.
PFE(Pfizer), BMY(Bristol-Myers Squibb), and NVS(Novartis) face pipeline risks as CAR-T safety concerns and drug-pricing policy complicate otherwise solid franchises.
TAK(Takeda) is using AI to compress regulatory-document preparation time, a potentially meaningful productivity advantage for future development programs.

Actionable Ideas (Positive)

Overweight GH(Guardant Health), NTRA(Natera), and TEM(Tempus AI). Payer coverage and FDA approvals are moving liquid biopsy from clinical promise toward scalable reimbursement.
Favor CNC(Centene) and ELV(Elevance Health). Margin recovery, tighter pricing, and lower medical-cost ratios are more durable catalysts than membership growth alone.
Buy MRNA(Moderna) on continued clinical confirmation. The melanoma Phase 3 outcome creates a credible second growth engine beyond COVID vaccines.
Prefer GMED(Globus Medical) and MDT(Medtronic) for device exposure. Consistent earnings beats, procedure growth, and differentiated platforms support higher-quality compounding.
Maintain a positive view on LLY(Eli Lilly) and VRTX(Vertex Pharmaceuticals). Both have strong commercial engines and pipeline optionality, though position sizing should reflect policy and valuation risk.

Actionable Ideas (Negative)

Avoid BAX(Baxter), HCA(HCA Healthcare), and ZTS(Zoetis) until earnings momentum improves. Stagnant revenue, weaker guidance, and poor capital returns indicate structural rather than temporary pressure.
Stay cautious on NVO(Novo Nordisk), PFE(Pfizer), and BMY(Bristol-Myers Squibb). Oral GLP-1 competition, government pricing, and CAR-T safety setbacks threaten future margin and pipeline assumptions.
Treat RPRX(Royalty Pharma) as event-risk exposure. Its leveraged balance sheet and capped royalties make a negative FDA decision on rusfertide particularly damaging.

Industrials

Theme

Industrials are splitting into AI- and infrastructure-linked winners and mature companies exposed to weak housing, cyclical demand, or execution problems. Defense, specialty materials, automation, and mission-critical services remain the strongest pockets.

Movers

CAT(Caterpillar), FIX(Comfort Systems USA), PWR(Quanta Services), URI(United Rentals), ECG(Everus Construction Group), and EME(EMCOR) are leveraged to grid expansion, construction, and data-center buildouts.
CACI(CACI International), HII(Huntington Ingalls), LMT(Lockheed Martin), NOC(Northrop Grumman), RTX(RTX), BA(Boeing), GD(General Dynamics), KTOS(Kratos Defense), and SAIC(SAIC) are benefiting from durable defense procurement and missile-defense demand.
KBR(KBR) added a $1.1 billion weather infrastructure contract while preparing to spin out Trinzic, strengthening its government-technology narrative.
HWM(Howmet Aerospace) sold off after SpaceX indicated it would manufacture some turbine components internally. Analysts view this as evidence of capacity scarcity, but the vertical-integration risk is real.
MMM(3M), EMR(Emerson Electric), CSL(Carlisle Companies), GGG(Graco), and FERG(Ferguson) show stronger execution through specialty products, automation, and solutions-oriented acquisitions.
HON(Honeywell), CMI(Cummins), RRX(Regal Rexnord), and AOS(A. O. Smith) face weaker regional demand, margin pressure, or stalled growth.
ACM(AECOM), RBC(RBC Bearings), and TDY(Teledyne) were hit by the broader valuation reset despite strong backlogs or earnings beats.

Actionable Ideas (Positive)

Favor FIX(Comfort Systems USA), PWR(Quanta Services), and URI(United Rentals) for infrastructure exposure. Their backlogs, cash generation, and exposure to grid and data-center investment provide stronger visibility than traditional construction demand.
Overweight CACI(CACI International), HII(Huntington Ingalls), NOC(Northrop Grumman), and RTX(RTX). Multi-year defense contracts are creating durable revenue visibility independent of the consumer cycle.
Buy CRS(Carpenter Technology) and MMM(3M) on pullbacks. Specialty materials, aerospace exposure, and operating improvement support a higher-quality industrial recovery.
Use HWM(Howmet Aerospace) selectively after the selloff. Turbine demand is expanding rapidly, but the thesis requires monitoring customer insourcing and pricing power.

Actionable Ideas (Negative)

Avoid BLDR(Builders FirstSource), LOW(Lowe’s), and POOL(Pool Corporation) until housing demand improves. Falling housing starts and weak cash conversion are pressuring the entire residential construction chain.
Stay cautious on HON(Honeywell), CMI(Cummins), and RRX(Regal Rexnord). Weak organic growth and margin compression do not support their valuation premiums.
Do not chase RBC(RBC Bearings) after strong results. A 48.7x P/E combined with weak guidance creates substantial downside if aerospace momentum normalizes.

Transportation

Theme

Transportation data show a widening gap between asset-light operators with pricing or network advantages and capital-intensive carriers absorbing fuel and labor inflation. Airlines remain demand-resilient but margin-sensitive; freight results favor execution over scale.

Movers

DAL(Delta Air Lines) and UAL(United Airlines) delivered strong revenue and demand, with international expansion and premium travel supporting longer-term growth. Fuel costs remain the primary margin risk.
AAL(American Airlines) exposed the sector’s vulnerability: revenue rose 16.3%, but an 83.3% fuel-cost increase caused an EPS miss and weaker guidance.
EXPD(Expeditors) delivered the strongest logistics result, with 32.1% revenue growth and an 18.6% EPS beat. CHRW(C.H. Robinson) also beat sharply, but the stock sold off, showing skepticism toward freight durability.
FDX(FedEx) and UPS(United Parcel Service) produced revenue growth but weaker profit confidence. UPS’s 91% payout ratio and halted dividend growth are material concerns.
CVNA(Carvana) is deepening vertical integration through reconditioning and embedded insurance, improving control over inventory velocity and customer lifetime value.
NSC(Norfolk Southern) and UNP(Union Pacific) face regulatory delay around their proposed merger, increasing political and community scrutiny.
IRDM(Iridium Communications) is expanding into maritime safety communications with a mission-critical terminal partnership with Furuno.
STNG(Scorpio Tankers) and TEN(Tsakos Energy Navigation) benefit from strong refined-product shipping demand and contracted revenue visibility.

Actionable Ideas (Positive)

Buy EXPD(Expeditors) on weakness. The combination of revenue acceleration, EPS upside, and balance-sheet quality is superior to peers still struggling to restore margins.
Favor DAL(Delta Air Lines) and UAL(United Airlines) over AAL(American Airlines). Premium international exposure and better execution provide greater protection against fuel inflation.
Accumulate IRDM(Iridium Communications). Maritime safety requirements are non-discretionary, and the Furuno partnership can expand recurring network demand.

Actionable Ideas (Negative)

Avoid AAL(American Airlines) while fuel prices remain elevated. The company is absorbing cost inflation to defend share, creating direct margin compression.
Stay negative on UPS(United Parcel Service) until payout risk improves. Slow growth, a 91% payout ratio, and the end of its dividend-growth streak create an unattractive income-risk profile.
Remain cautious on NSC(Norfolk Southern) and UNP(Union Pacific). Merger delays increase the probability of concessions, prolonged regulatory costs, or a failed transaction.

Consumer Discretionary

Theme

Consumer discretionary is bifurcating between value, experiences, and differentiated brands and retailers exposed to weaker traffic, higher costs, and promotional pressure. The housing slowdown and fragile confidence remain broad sector headwinds.

Movers

WMT(Walmart) used nearly $3 billion of tariff refunds to lower prices and intensify competition, pressuring KR(Kroger) and ACI(Albertsons). Walmart’s own earnings reaction showed that even value leaders face slowing traffic.
TGT(Target), FIVE(Five Below), ROST(Ross Stores), TJX(TJX Companies), and DLTR(Dollar Tree) are gaining relative share through value positioning and strong merchandising.
BURL(Burlington Stores), DKS(Dick’s Sporting Goods), NKE(Nike), LULU(Lululemon), ONON(On Holding), and TPR(Tapestry) illustrate rising athletic and apparel competition. Dick’s integration of Foot Locker has caused margin compression, while Gap’s accessories push directly threatens Coach.
ABNB(Airbnb), BKNG(Booking Holdings), EXPE(Expedia), HLT(Hilton), MAR(Marriott), IHG(InterContinental Hotels), and RCL(Royal Caribbean) show resilient travel demand, but valuation and international growth expectations vary sharply.
DASH(DoorDash), UBER(Uber), and LYFT(Lyft) are diverging. DoorDash and Uber are building broader logistics and autonomous-mobility ecosystems, while Lyft faces weaker scale and rising labor-policy risk.
MCD(McDonald’s), SBUX(Starbucks), CMG(Chipotle), CZR(Caesars Entertainment), LVS(Las Vegas Sands), and WYNN(Wynn Resorts) reflect different degrees of pricing power, international exposure, and margin execution.
CHWY(Chewy), ETSY(Etsy), WSM(Williams-Sonoma), and DECK(Deckers Brands) retain differentiated growth narratives despite a difficult consumer backdrop.
TSLA(Tesla), BYDDY(BYD), NIO(NIO), HMC(Honda), TM(Toyota), STLA(Stellantis), and RACE(Ferrari) face contrasting EV, tariff, pricing, and product-cycle dynamics.
OPEN(Opendoor), ZG(Zillow), and RKT(Rocket Companies) remain tied to housing affordability and high rates.

Actionable Ideas (Positive)

Overweight ROST(Ross Stores), TJX(TJX Companies), FIVE(Five Below), and TGT(Target). Value-oriented traffic and merchandising are winning share as consumers trade down.
Favor ABNB(Airbnb), BKNG(Booking Holdings), and DASH(DoorDash). Platform scale, improving ecosystems, and resilient travel or delivery demand provide stronger structural support than traditional retailers.
Buy SBUX(Starbucks) on weakness. International comp growth, debt reduction, and liquidity distinguish Starbucks from slower restaurant peers.
Use CHWY(Chewy) as a turnaround candidate. Vet Care, advertising, customer growth, and a low valuation create a credible re-rating path.

Actionable Ideas (Negative)

Short or underweight ACI(Albertsons) and KR(Kroger). Walmart